Fever duration enhanced biomarker sensitivity in diagnosing radiographically confirmed community-acquired pneumonia in children
- PMID: 39682005
- PMCID: PMC11976110
- DOI: 10.1111/apa.17531
Fever duration enhanced biomarker sensitivity in diagnosing radiographically confirmed community-acquired pneumonia in children
Abstract
Aim: Our aim was to examine how fever duration affected the ability of biomarkers to diagnose community-acquired pneumonia (CAP).
Methods: This was a retrospective cohort study of children aged 2-18 years who attended the emergency department at Schneider Children's Medical Centre of Israel with CAP from June 2015 to May 2020. The children underwent biomarker measurements and chest radiographs and optimal biomarker thresholds were identified. Biomarker predictions of x-ray positive CAP were analysed, using receiver operating characteristic curves and area under the curve calculations.
Results: We screened 3346 children, 509 met the inclusion criteria and 363 of those had x-ray positive CAP. White blood counts of >15 000/mm3 and absolute neutrophil counts of >11 200/mm3 showed significant discriminatory power on day 2 of a fever. A neutrophil to lymphocyte ratio (NLR) of >4.5 displayed significant discriminatory power from days 2-5 and peaked on day 4. C-reactive protein of 6.23 mg/dL was discriminatory on day 4.
Conclusion: Fever duration affected how effectively biomarkers diagnosed x-ray positive CAP and all were unreliable on day 1. The NLR showed the most consistent reliability and may be suitable for clinical decision-making. Fever duration should be considered to optimise diagnostic accuracy.
Keywords: C‐reactive protein; biomarkers; community‐acquired pneumonia; emergency department; neutrophil–lymphocyte ratio.
© 2024 The Author(s). Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures


Similar articles
-
Neutrophil-to-Lymphocyte Ratio in Adult Community-Acquired Pneumonia Patients Correlates with Unfavorable Clinical Outcomes.Clin Lab. 2019 May 1;65(5). doi: 10.7754/Clin.Lab.2018.181042. Clin Lab. 2019. PMID: 31115235
-
Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia.Pediatrics. 2020 Jun;145(6):e20193728. doi: 10.1542/peds.2019-3728. Epub 2020 May 13. Pediatrics. 2020. PMID: 32404432 Free PMC article.
-
C-reactive protein and serum amyloid A protein as complementary biomarkers in differentiating viral and bacterial community-acquired pneumonia in children.BMC Pediatr. 2025 Jun 2;25(1):445. doi: 10.1186/s12887-025-05770-x. BMC Pediatr. 2025. PMID: 40457268 Free PMC article.
-
Accuracy of Biomarkers for the Diagnosis of Adult Community-acquired Pneumonia: A Meta-analysis.Acad Emerg Med. 2020 Mar;27(3):195-206. doi: 10.1111/acem.13889. Epub 2020 Feb 26. Acad Emerg Med. 2020. PMID: 32100377
-
Lung ultrasound in diagnosing pneumonia in the emergency department: a systematic review and meta-analysis.Eur J Emerg Med. 2018 Oct;25(5):312-321. doi: 10.1097/MEJ.0000000000000517. Eur J Emerg Med. 2018. PMID: 29189351
References
-
- Stop Pneumonia . A global advocacy initiative to end pneumonia [Webpage]. 2024. Accessed October 21, 2024. https://stoppneumonia.org/about‐us/
-
- Bill & Melinda Gates Foundation . Pneumonia: Advancing Global Health Through Prevention and Treatment Programs [Webpage]. Accessed October 21, 2024. https://www.gatesfoundation.org/our‐work/programs/global‐health/pneumonia
-
- World Health Organization (WHO) . Pneumonia: key facts on causes, prevention, and global impact. [Webpage]. 2022. Accessed October 21, 2024. https://www.who.int/news‐room/fact‐sheets/detail/pneumonia
-
- Madhi SA, De Wals P, Grijalva CG, et al. The burden of childhood pneumonia in the developed world: a review of the literature. Pediatr Infect Dis J. 2013;32:e119‐e127. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous